Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,188.34
(
-1.10%
)
News Focus
News Focus
Post# of 257580
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122988
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: iwfal post# 80343

Wednesday, 07/01/2009 10:02:29 PM

Wednesday, July 01, 2009 10:02:29 PM

Post# of 257580

The point of disagreement within the scientific community isn't about CRP causation, but whether inflammation is a separate causation path potentially separately benefitted by statins. And CRP is a reliable proxy for that path.

Agreed. When viewed under this lens, the NYT article in #msg-39219495 is not one of Gina Kolata’s better efforts.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today